Hypofractionated Palliative Radiotherapy (17 Gy per two fractions) in Advanced Non–Small-Cell Lung Carcinoma Is Comparable to Standard Fractionation for Symptom Control and Survival: A National Phase III Trial

S. Sundstrøm,Roy M. Bremnes,Ulf Aasebø,Steinar Aamdal,Reidulv Hatlevoll,Paal Brunsvig,Dag Clement Johannessen,Olbjørn Klepp,Peter Fayers,Stein Kaasa

Hypofractionated Palliative Radiotherapy (17 Gy per two fractions) in Advanced Non–Small-Cell Lung Carcinoma Is Comparable to Standard Fractionation for Symptom Control and Survival: A National Phase III Trial

2004

S. Sundstrøm
Roy M. Bremnes
Ulf Aasebø
Steinar Aamdal
Reidulv Hatlevoll
Paal Brunsvig
Dag Clement Johannessen
Olbjørn Klepp
Peter Fayers
Stein Kaasa

Hypofractionated Palliative Radiotherapy (17 Gy per two fractions) in Advanced Non–Small-Cell Lung Carcinoma Is Comparable to Standard Fractionation for Symptom Control and Survival : A National Phase III Trial

Keywords:

Respiratory disease
Fractionation
Cancer
Small Cell Lung Carcinoma
Carcinoma
Radiation therapy
Lung cancer
Pathology
Lung
Medicine
Randomized controlled trial
Survival analysis
Clinical trial
Dose fractionation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

137

Citations